IJE Advance Access originally published online on March 22, 2006
International Journal of Epidemiology 2006 35(4):1001-1008; doi:10.1093/ije/dyl049
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Published by Oxford University Press on behalf of the International Epidemiological Association
Respiratory Disease |
Plasma fibrinogen and lung function: the CARDIA Study
1 Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
2 Department of Nutrition, University of Oslo, Oslo, Norway.
3 Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
4 Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
* Corresponding author. Division of Epidemiology, School of Public Health, University of Minnesota, 1300 South 2nd Street, Suite 300, Minneapolis, MN 55454, USA. E-mail: Jacobs{at}epi.umn.edu.
Background We hypothesized that fibrinogen, as a marker of chronic inflammation, is inversely associated with forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1) in healthy persons.
Methods The CARDIA cohort started in 1985 and included black and white men and women, aged 18–30, from the general population. Spirometry testing conducted at years 5 and 10 [FVC, FEV1, and their ratio (FEV1/FVC)] was studied relative to plasma fibrinogen levels measured at year 5 (cross-sectional n = 4040) and at year 7 (longitudinal n = 3001), controlling for race, sex, age, height, smoking, asthma, body mass index, physical activity, birth control pill use, and alcohol intake.
Results In cross-sectional analyses, FVC at year 5 was lower by 166 ml (95% confidence interval 116–216 ml) in the highest vs lowest year 5 fibrinogen quartile. At year 10, holding year 5 FVC and change in fibrinogen (year 7–year 5) constant, the difference in FVC between the highest and the lowest year 5 fibrinogen quartiles widened by 67 ml (95% CI 31–103 ml). The corresponding differences for FEV1 were 166 ml (95% CI 146–253 ml) at year 5 and 45 ml (95% CI 11–80 ml) widening by year 10. The FEV1/FVC ratio was unrelated to plasma fibrinogen.
Conclusion These findings are consistent with the hypothesis that fibrinogen, possibly as a marker for chronic low-grade inflammation, is associated with modest deterioration of lung function in healthy young adults.
Keywords Fibrinogen, FEV1, FVC, FEV1/FVC ratio, lung function, inflammation, smoking, asthma, BMI
Accepted 2 March 2006
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Sunyer, R. Pistelli, E. Plana, M. Andreani, F. Baldari, M. Kolz, W. Koenig, J. Pekkanen, A. Peters, and F. Forastiere Systemic inflammation, genetic susceptibility and lung function Eur. Respir. J., July 1, 2008; 32(1): 92 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J Hancox, R. Poulton, J. M Greene, S. Filsell, C. R McLachlan, F. Rasmussen, D R. Taylor, M. J A Williams, A. Williamson, and M. R Sears Systemic inflammation and lung function in young adults Thorax, December 1, 2007; 62(12): 1064 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W Fogarty, S. Jones, J. R Britton, S. A Lewis, and T. M McKeever Systemic inflammation and decline in lung function in a general population: a prospective study Thorax, June 1, 2007; 62(6): 515 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D Sin and S. P. Man Commentary: Fuelling the fire--systemic inflammation and development of lung disease in the general community Int. J. Epidemiol., August 1, 2006; 35(4): 1008 - 1010. [Full Text] [PDF]
|
|